학술논문
Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Document Type
Artikel
Author
Source
European journal of haematology. 109(6):749-754
Subject
Language
English
English
English
ISSN
1600-0609